Jump Trading’s Quest Diagnostics DGX Stock Holding History

Jump Trading’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,549	Closed	-$251K	–	382
2017 Q4	$251K	Buy	+2,549	New	+$242K	0.03%	281

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jump Trading's DGX Position: Q1 2018 in Review

Jump Trading sold out of Quest Diagnostics (DGX) in Q1 2018, closing a stake of 2,549 shares — an estimated $251K sold.

Jump Trading first reported a position in DGX in Q4 2017 and held it in 1 quarter. The position peaked at $251K in Q4 2017. 653 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

Jump Trading reported no remaining Quest Diagnostics position as of Q1 2018 after selling out during the quarter.
Jump Trading sold 2,549 Quest Diagnostics shares in Q1 2018, an estimated $251K.
Jump Trading first reported a position in Quest Diagnostics in Q4 2017 and held it in 1 quarter.
Jump Trading's Quest Diagnostics position peaked at $251K in Q4 2017.
653 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on Jump Trading's 13F filing for Q1 2018, filed 11 May 2018.